Leon R, Borner T, Stein L, Urrutia N, De Jonghe B, Schmidt H
Neuropharmacology. 2021; 187:108477.
PMID: 33581143
PMC: 8040630.
DOI: 10.1016/j.neuropharm.2021.108477.
ODonnell K, Gould T
Neurosci Biobehav Rev. 2007; 31(6):932-62.
PMID: 17532044
PMC: 2150568.
DOI: 10.1016/j.neubiorev.2007.04.002.
Wegener G, Bandpey Z, Heiberg I, Mork A, Rosenberg R
Psychopharmacology (Berl). 2003; 166(2):188-94.
PMID: 12552361
DOI: 10.1007/s00213-002-1341-6.
Diksic M, Grdisa M
Neurochem Res. 1995; 20(11):1353-60.
PMID: 8786822
DOI: 10.1007/BF00992511.
Uchitomi Y, Yamawaki S
Psychopharmacology (Berl). 1993; 112(1):74-9.
PMID: 7871012
DOI: 10.1007/BF02247365.
Effects of repeated lithium administration on the subcellular distribution of 5-hydroxytryptamine in rat brain.
Atterwill C, Tordoff A
Br J Pharmacol. 1982; 76(3):413-21.
PMID: 7104517
PMC: 2071803.
DOI: 10.1111/j.1476-5381.1982.tb09235.x.
Effects of acute lithium administration on conditioned avoidance behavior and monoamine synthesis in rats.
Berggren U, Ahlenius S, Engel J
J Neural Transm. 1980; 47(1):1-10.
PMID: 6965708
DOI: 10.1007/BF01256634.
Clinical and neuropathological aspects of long-term damage to the central nervous system after lithium medication.
PEIFFER J
Arch Psychiatr Nervenkr (1970). 1981; 231(1):41-60.
PMID: 6797383
DOI: 10.1007/BF00342829.
Effect of lithium on central metabolism of 5-hydroxytryptamine.
Poitou P, Guerinot F, Bohuon C
Psychopharmacologia. 1974; 38(1):75-80.
PMID: 4851658
DOI: 10.1007/BF00421289.
Effect of chronic lithium treatment on monoamine metabolism in rat brain.
Schubert J
Psychopharmacologia. 1973; 32(3):301-11.
PMID: 4762238
DOI: 10.1007/BF00422153.
Effect of lithium on the blood and intestinal serotonin contents of rats.
Iwata H, Okamoto H
Experientia. 1973; 29(8):988-9.
PMID: 4733329
DOI: 10.1007/BF01930421.
Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children.
Campbell M, Fish B, Korein J, Shapiro T, Collins P, Koh C
J Autism Child Schizophr. 1972; 2(3):234-63.
PMID: 4567547
DOI: 10.1007/BF01537617.
The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
Grahame-Smith D, Green A
Br J Pharmacol. 1974; 52(1):19-26.
PMID: 4281339
PMC: 1776910.
DOI: 10.1111/j.1476-5381.1974.tb09682.x.
The role of 5-hydroxytryptamine and noradrenaline in the hyperthermic reaction induced by pethidine in rabbits pretreated with pargyline.
FAHIM I, Ismail M, Osman O
Br J Pharmacol. 1972; 46(3):416-22.
PMID: 4266343
PMC: 1666541.
DOI: 10.1111/j.1476-5381.1972.tb08139.x.
Estimation of the rate of 5-HT synthesis in the mouse brain by various methods.
Morot-Gaudry Y, Hamon M, Bourgoin S, Ley J, Glowinski J
Naunyn Schmiedebergs Arch Pharmacol. 1974; 282(3):223-38.
PMID: 4152592
DOI: 10.1007/BF00501231.
Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats.
Berggren U
J Neural Transm. 1985; 64(3-4):239-50.
PMID: 4086991
DOI: 10.1007/BF01256470.
Effects of short-term lithium administration on tryptophan levels and 5-hydroxytryptamine synthesis in whole brain and brain regions in rats.
Berggren U
J Neural Transm. 1987; 69(1-2):115-21.
PMID: 3585316
DOI: 10.1007/BF01244102.
Chronic lithium: desensitization of autoreceptors mediating serotonin release.
Wang H, Friedman E
Psychopharmacology (Berl). 1988; 94(3):312-4.
PMID: 3128806
DOI: 10.1007/BF00174681.
The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism.
Goodwin G, de Souza R, Wood A, Green A
Psychopharmacology (Berl). 1986; 90(4):488-93.
PMID: 2949333
DOI: 10.1007/BF00174066.
Lithium and serotonin function: implications for the serotonin hypothesis of depression.
Price L, Charney D, Delgado P, Heninger G
Psychopharmacology (Berl). 1990; 100(1):3-12.
PMID: 2404294
DOI: 10.1007/BF02245781.
